Erinacine


Erinacines are natural substances isolated from the mycelium of Hericium erinaceus. They belong to the group of cyathin diterpenoids and are subjects of pharmacological research, which largely focuses on the benefits of erinacine on the brain. All erinacines are able to readily cross the blood–brain barrier in vivo, which largely influences the bioavailability of the compounds in the brain.

Erinacine A

Erinacine A, isolated from the cultured mycelia of Hericium erinaceus, the main representative of this compounds group, has an enhancing effect on nerve growth factor synthesis in vitro. It also increases the levels of catecholamines in the central nervous system of rats.. Erinacine A has been observed to lead to the activation of antioxidant pathways including the transcription factor Nrf2.
Stimulator of nerve growth factor synthesis in vitro,weak cytotoxicity against PC12 cells,Anti‐methicillin-resistant Staphylococcus aureus activity
Erinacine A has also been prepared by total synthesis.

Erinacine B

Stimulator of NGF synthesis in vitro

Erinacine C

Erinacine C has also been observed to activate the transcription factor Nrf2 and has been observed to play a role in neurogenesis and neuroplasticity.
Stimulator of NGF synthesis in vitro

Erinacine D

Stimulators of NGF synthesis

Erinacine E

Erinacine E is a kappa opioid receptor agonist.
Stimulators of NGF synthesis by astrocytes

Erinacine F

Stimulators of NGF synthesis by astrocytes

Erinacine G

Stimulators of NGF synthesis by astrocytes

Erinacine H

Obvious NGF stimulating activity, 33.3 g/mL, five times more NGF

Erinacine I

No stimulatory activity of NGF synthesis in astrocytes

Erinacine J

Inactive against MRSA

Erinacine K

Anti-MRSA activity

Erinacine L

Erinacine LĀ is the only xyloside-cyathane diterpene currently found to contain a hemiacetal group. EL with hemiacetal group has excellent neurotrophic and anti-neuroinflammatory activities, suggesting that the hemiacetal moiety may be an essential pharmacophore for the treatment of neurodegenerative diseases.

Erinacine P

Significant neurotrophic effects

Erinacines Q1,Q2

Erinacine R

Erinacine S

Erinacine S has been shown to reduce neuropathic pain in vivo and can increase myelination in vivo.
Elevated levels of insulin-degrading enzymes

Erinacine T

Promotion of PC12 cells differentiation and axonal growth

Erinacine U

Promote the neurite growth of PC12 cells (2.5single bond10 μmol/L, at 10 μmol/L: percentage of neurite-bearing cells: 76.31 %

Erinacine V

Promote the neurite growth of PC12 cells

Erinacine W

Erinacine X

Erinacine Y

Erinacines Z1,Z2

Z1- Promote PC12 cell differentiation and neurite growth
Z2- Promote PC12 cell differentiation and neurite growth

Erinacines Za, Zb, Zc